Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Denali Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.

Get DNLI alerts

About Alexander O. Schuth

Alexander O. Schuth is recorded as COO at Denali Therapeutics Inc. (DNLI). The newest filing on record that lists Alexander O. Schuth as COO at Denali Therapeutics Inc. (DNLI) is dated April 19, 2022. The proxy statement of Denali Therapeutics Inc. reports total compensation of $4,258,045 for Alexander O. Schuth in fiscal 2025, including a base salary of $552,000. Disclosed compensation is on record for 9 fiscal years. Alexander O. Schuth has spoken on 1 investor event across 1 company, most recently for Denali Therapeutics Inc. on May 12, 2026. Denali Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Denali Therapeutics Inc. includes Ryan J. Watts (CEO and Board Member), Alexander Schuth (CFO), Steve E. Krognes (CFO and Board Member) and 7 others.

Alexander O. Schuth on recent calls

“Well, again, thank you to Zine for inviting us for a fantastic conference. But really also thank you for following us for many years now.”
COO, BofA Securities Health Care Conference 2026 ·

Affiliation history

Company network

Leadership on record at Denali Therapeutics Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Denali Therapeutics Inc. (DNLI) $552,000 $4,258,045
2024 Denali Therapeutics Inc. (DNLI) $535,600 $4,022,759
2023 Denali Therapeutics Inc. (DNLI) $520,000 $4,169,183
2022 Denali Therapeutics Inc. (DNLI) $500,000 $5,692,052
2021 Denali Therapeutics Inc. (DNLI) $465,129 $6,530,026
2020 Denali Therapeutics Inc. (DNLI) $449,400 $4,203,402
2019 Denali Therapeutics Inc. (DNLI) $428,000 $2,476,628
2018 Denali Therapeutics Inc. (DNLI) $400,000 $3,901,789
2017 Denali Therapeutics Inc. (DNLI) $369,008 $1,076,937

Recent activity